EUVIMEDEUVIMED entdecken
Crossref

Bridging Cytoskeletal and Epitranscriptomic Mechanisms: L-DOPA–Induced Microtubule Remodelling Meets m⁶A RNA Methylation in Neural Disorders

Sonu Kumar

Journal of Traditional Medicine & Applications · 2026

DOI: 10.33140/jtma.05.01.01 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Traditional Medicine & Applications, 2026. Verfasst von Sonu Kumar.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Parkinson’s disease (PD) is a progressive neurodegenerative disorder characterized by dopaminergic neuronal loss, α-synuclein aggregation, and disrupted motor and non-motor function [1]. Pharmacological replenishment of dopamine using L-3,4- dihydroxyphenylalanine (L-DOPA) remains the cornerstone of PD management; however, long-term exposure frequently induces motor fluctuations, dyskinesias, and cognitive side effects [2]. Recent mechanistic evidence reveals that L-DOPA itself, independent of its metabolic conversion to dopamine, can be aberrantly incorporated into neuronal microtubules, leading to structural and synaptic instability [3]. L-DOPA acts as a tyrosine analogue within the tubulin tyrosination–de–tyrosination cycle, where tubulin tyrosine ligase (TTL) catalyses its attachment to α-tubulin. The resulting L-Dopa–modified microtubules resist enzymatic removal by the vasohibin-1/small vasohibin-binding protein (VASH1–SVBP) complex, thereby accumulating in neurons and impairing cytoskeletal plasticity [3,4]. Functionally, this modification disrupts dendritic spine invasion, reduces excitatory synaptic density, and perturbs intracellular transport, culminating in synaptic weakening and neurofunctional decline. These findings introduce a cytoskeletal dimension to L-DOPA neurotoxicity, linking pharmacotherapy to microtubule dysregulation and altered neuronal connectivity. Understanding the molecular interface between L-DOPA metabolism and tubulin dynamics may inform strategies to mitigate long-term treatment complications and preserve synaptic integrity in PD.

Zitieren

APA

Kumar, S. (2026). Bridging Cytoskeletal and Epitranscriptomic Mechanisms: L-DOPA–Induced Microtubule Remodelling Meets m⁶A RNA Methylation in Neural Disorders. Journal of Traditional Medicine & Applications. https://doi.org/10.33140/jtma.05.01.01

Vancouver

Kumar S. Bridging Cytoskeletal and Epitranscriptomic Mechanisms: L-DOPA–Induced Microtubule Remodelling Meets m⁶A RNA Methylation in Neural Disorders. Journal of Traditional Medicine & Applications. 2026. doi:10.33140/jtma.05.01.01

BibTeX
@article{Kumar2026,
  author = {Kumar, Sonu},
  title = {Bridging Cytoskeletal and Epitranscriptomic Mechanisms: L-DOPA–Induced Microtubule Remodelling Meets m⁶A RNA Methylation in Neural Disorders},
  journal = {Journal of Traditional Medicine & Applications},
  year = {2026},
  doi = {10.33140/jtma.05.01.01}
}
Kostenlos starten →